We are live on ! Find out more
TNDM icon

Tandem Diabetes Care
TNDM

62 hedge funds and large institutions have $210M invested in Tandem Diabetes Care in 2014 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 16 increasing their positions, 29 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

5% less funds holding

Funds holding: 65 → 62 (-3)

20% less first-time investments, than exits

New positions opened: 12 | Existing positions closed: 15

21% less capital invested

Capital invested by funds: $266M → $210M (-$56.4M)

45% less repeat investments, than reductions

Existing positions increased: 16 | Existing positions reduced: 29

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $16K

Holders
62
Holders Change
-3
Holders Change %
-4.62%
% of All Funds
1.78%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
12
Increased
16
Reduced
29
Closed
15
Calls
–
Puts
$16K
Net Calls
-$16K
Net Calls Change
-$16K

Top Buyers

1
Franklin Resources
Franklin Resources
California
+$13.3M
2
CAM
Cortina Asset Management
Wisconsin
+$7.06M
3
RSCM
Rock Springs Capital Management
Maryland
+$3.32M
4
Jennison Associates
Jennison Associates
New York
+$3.01M
5
TCP
TAMRO Capital Partners
Virginia
+$2.45M

Top Sellers

1
PC
Pier Capital
Connecticut
-$2.68M
2
MACM
March Altus Capital Management
Connecticut
-$2.62M
3
VAM
Visium Asset Management
New York
-$2.55M
4
GTC
Ghost Tree Capital
New York
-$2.54M
5
PA
Perceptive Advisors
New York
-$2.34M
Name Holding Trade Value Shares
Change 		Change in
Stake
U
51
UBS
Switzerland
$60K +$57K +335 +1,047%
BA
52
BlackRock Advisors
Delaware
$57K -$23.3K -137 -28%
EA
53
Emerald Advisers
Pennsylvania
$30K -$920K -5,405 -97%
MWP
54
MYCIO Wealth Partners
Pennsylvania
$16K – – –
VFA
55
Virtus Fund Advisers
Connecticut
$12K +$12.3K +72 New
Manulife (Manufacturers Life Insurance)
56
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$9K -$117K -687 -92%
TRCT
57
Tower Research Capital (TRC)
New York
$6K +$6.64K +39 New
Royal Bank of Canada
58
Royal Bank of Canada
Ontario, Canada
$5K +$5.11K +30 New
TDC
59
Thompson Davis & Co
Virginia
$4K – – –
Bank of Montreal
60
Bank of Montreal
Ontario, Canada
$4K +$3.91K +23 New
Barclays
61
Barclays
United Kingdom
$2K -$3.74K -22 -61%
Citigroup
62
Citigroup
New York
$1K -$23K -135 -95%
GTC
63
Ghost Tree Capital
New York
– -$2.54M -11,500 Closed
PA
64
Perceptive Advisors
New York
– -$2.34M -10,590 Closed
PAM
65
Panagora Asset Management
Massachusetts
– -$1.44M -6,494 Closed
EMFAT
66
Emerald Mutual Fund Advisers Trust
Pennsylvania
– -$1.16M -5,234 Closed
DCM
67
Driehaus Capital Management
Illinois
– -$1M -4,530 Closed
MHP
68
Manatuck Hill Partners
Connecticut
– -$884K -4,000 Closed
ARC
69
Absolute Return Capital
Massachusetts
– -$739K -3,345 Closed
Jane Street
70
Jane Street
New York
– -$731K -3,310 Closed
SCA
71
SAC Capital Advisors
Connecticut
– -$623K -2,820 Closed
SIM
72
SSI Investment Management
California
– -$415K -1,882 Closed
PP
73
PDT Partners
New York
– -$411K -1,860 Closed
Two Sigma Investments
74
Two Sigma Investments
New York
– -$246K -1,110 Closed
MLICM
75
Metropolitan Life Insurance Company (MetLife)
New York
– -$207K -937 Closed
1 2
3
4

TNDM Hedge Fund Activity: Q2 2014 in Review

62 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in Tandem Diabetes Care (TNDM) for Q2 2014, worth a combined $210M — down 21% from $266M a quarter earlier.

Sellers outnumbered buyers: 15 funds closed out of TNDM and 12 opened new positions — a net loss of 3 holders — while 29 trimmed existing stakes and 16 added.

The largest buyer was Franklin Resources, adding an estimated $13.3M. The largest seller was Pier Capital, cutting an estimated $2.68M.

  • 62 institutional investors held Tandem Diabetes Care (TNDM) as of Q2 2014, down from 65 in Q1 2014.
  • Funds reported $210M of Tandem Diabetes Care stock for Q2 2014, down 21% quarter-over-quarter.
  • 12 funds opened new Tandem Diabetes Care positions in Q2 2014 and 15 closed out, a net change of -3 holders.
  • The largest Tandem Diabetes Care buyer in Q2 2014 was Franklin Resources, an estimated $13.3M added.
  • The largest Tandem Diabetes Care seller in Q2 2014 was Pier Capital, an estimated $2.68M sold.

Based on aggregated 13F filings for Q2 2014.